We are live on ! Find out more
ELAN icon

Elanco Animal Health

418 hedge funds and large institutions have $5.9B invested in Elanco Animal Health in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 160 increasing their positions, 144 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $110M | Put options by funds: $27.5M

11% more repeat investments, than reductions

Existing positions increased: 160 | Existing positions reduced: 144

1% more ownership

Funds ownership: 99.28%100.28% (+1%)

5% less funds holding

Funds holding: 438418 (-20)

22% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 81

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

36% less capital invested

Capital invested by funds: $9.18B → $5.9B (-$3.28B)

Holders
418
Holders Change
-20
Holders Change %
-4.57%
% of All Funds
7.2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
63
Increased
160
Reduced
144
Closed
81
Calls
$110M
Puts
$27.5M
Net Calls
+$82.2M
Net Calls Change
+$85.6M
Name Holding Trade Value Shares
Change
Change in
Stake
SCA
276
Snowden Capital Advisors
New York
$256K -$55.8K -3,193 -13%
BL
277
Balentine LLC
Georgia
$256K +$360K +20,591 New
ECM
278
Estabrook Capital Management
New York
$252K -$43.7K -2,500 -11%
HAIM
279
Hunter Associates Investment Management
Pennsylvania
$233K +$57.7K +3,300 +21%
OC
280
Oppenheimer & Co
New York
$227K -$70.3K -4,019 -18%
JCM
281
Jacobi Capital Management
Pennsylvania
$225K +$30.7K +1,759 +11%
CS
282
Candriam SCA
Luxembourg
$223K -$84.5K -4,835 -21%
VPIM
283
Vanguard Personalized Indexing Management
California
$215K +$303K +17,331 New
PCM
284
Prelude Capital Management
New York
$211K +$298K +17,021 New
PWMAG
285
Pinnacle Wealth Management Advisory Group
New Jersey
$205K -$45.4K -2,600 -14%
Rafferty Asset Management
286
Rafferty Asset Management
New York
$203K +$100K +5,724 +54%
DC
287
Davenport & Co
Virginia
$201K -$105K -6,024 -27%
CM
288
CastleKnight Management
New York
$194K
CG
289
Cutler Group
California
$192K +$210K +12,004 +343%
BA
290
Bennicas & Associates
California
$191K -$14K -800 -5%
CCB
291
Cutter & Co Brokerage
Missouri
$188K -$688K -39,366 -72%
PTC
292
Petrus Trust Company
Texas
$188K +$265K +15,135 New
SACTSONJ
293
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$186K
BL
294
BFSG LLC
California
$184K +$14.3K +820 +6%
TWC
295
TD Waterhouse Canada
Ontario, Canada
$183K +$251K +14,334 New
LSAG
296
Lake Street Advisors Group
New Hampshire
$179K +$253K +14,452 New
US Bancorp
297
US Bancorp
Minnesota
$178K -$124K -7,116 -33%
PGH
298
Partners Group Holding
Switzerland
$174K -$46.8K -2,675 -16%
MPPW
299
Mitchell & Pahl Private Wealth
Oklahoma
$170K +$34.4K +1,968 +17%
GC
300
Guggenheim Capital
Illinois
$168K +$26.3K +1,506 +13%

ELAN Hedge Fund Activity: Q3 2022 in Review

418 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2022, worth a combined $5.9B — down 36% from $9.18B a quarter earlier.

Sellers outnumbered buyers: 81 funds closed out of ELAN and 63 opened new positions — a net loss of 18 holders — while 144 trimmed existing stakes and 160 added.

The largest buyer was Janus Henderson Group, adding an estimated $212M. The largest seller was Aristotle Capital Management, cutting an estimated $411M.

  • 418 institutional investors held Elanco Animal Health (ELAN) as of Q3 2022, down from 438 in Q2 2022.
  • Funds reported $5.9B of Elanco Animal Health stock for Q3 2022, down 36% quarter-over-quarter.
  • 63 funds opened new Elanco Animal Health positions in Q3 2022 and 81 closed out, a net change of -18 holders.
  • The largest Elanco Animal Health buyer in Q3 2022 was Janus Henderson Group, an estimated $212M added.
  • The largest Elanco Animal Health seller in Q3 2022 was Aristotle Capital Management, an estimated $411M sold.

Based on aggregated 13F filings for Q3 2022.